Laurel Evans

Laurel Evans is a Clinical Project Coordinator at Axsome Therapeutics, Inc., since May 2023, where responsibilities include managing a phase 3 clinical trial for AXS-05 focused on Alzheimer’s Disease agitation. Previous experience includes serving as a Study Coordinator at the University of California, San Francisco, facilitating a cross-campus study on circulating tumor DNA for lung cancer risk stratification, and managing a team of researchers. Laurel has also worked as an analyst at IPwe, a data science intern at NExTNet Inc., an academic intern at UC Berkeley, and a research assistant at the University of California, Berkeley. Laurel holds a Bachelor of Arts in Molecular Biology from the University of California, Berkeley, with study experiences at UCL.